"To provide a competitive representation of the North American, European, Asian Biomedical sector and to encourage unhindered interactivity for Canadian, U.S., European, and Asian Biomedical players through CanBiotech."
The founders of CanBiotech from institutions including M.I.T, Harvard, Brown, McGill, University of Waterloo and University of Toronto, aim to create a central hub for the bio-medical industry through its portals and marketplaces, with equal, yet distinct representation of each of the bio-medical sectors: therapeutics/biopharmaceuticals, agrifood, devices/diagnostics.
The founders of CanBiotech bring over 13 years experience in molecular biology, cancer biology, gene therapy, drug delivery, tissue engineering, bio-IT, biopharmaceutical business development, software and web development from various arenas including the biopharmaceutical industry, the agbiotech industry, the financial industry and the public sector.
CanBiotech, a private venture, is a company whose central premise is forming partnerships and creating synergies with a focus on the outsourcing of biomedical research and business services through CanBiotech’s online marketplaces or through CanBiotech’s physical arm: CanBiotech Consulting. The goal is to enhance the biomedical industry, enabling a new process of discovery and development, with an equal opportunity provided to all players, by fostering both cross-border interactivity between Canadian and U.S. biomedical companies as well as provide for international partnering opportunities for the biomedical industry.
The medical devices and diagnostics sector is represented on the BioDevicesBiz Portal and B2B Marketplace.